The activation of Erk1/2 induces proliferative signals that may contribute to tumorigenesis or cancer growth, as seen by the presence of activated Erk1/2 in a variety of human cancer tissues and cell lines, including pituitary adenoma [24-27]. Here, MAPK3 is linked to cancer.